BLACR

Bellevue Life Sciences Acquisition Corp. Rights
BLACR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLACR was delisted on the 14th of February, 2025.

Back to rankings

28 hedge funds and large institutions have $550K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.02K
2
+$219

Top Sellers

1
-$18.1K
2
-$538
3
-$436
4
Citadel Advisors
Citadel Advisors
Florida
-$31
5
UBS Group
UBS Group
Switzerland
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$87.2K
2
$57.2K
3
$39.3K
4
$36.4K
5
$35.3K
6
$34K
7
$31.3K
8
$29.3K
9
$28.8K
10
$26.1K
11
$20.3K
12
$18.4K
13
$17.1K
14
$15.6K
15
$13.3K
16
$10.4K
17
$10.4K
18
$10.3K
19
$8K
20
$4.74K
21
$4K
22
$2.95K
23
$2.53K
24
$2.27K
25
$2K
1
2